STRUCTURED CONTENT
303
ActaDV ActaDV
Advances in dermatology and venereology Acta Dermato-Venereologica
Skin biology and inflammation
The” Alarmins” HMBG1 and IL-33 Downregulate Structural Skin Barrier Proteins and Impair Epidermal Growth, U. Nygaard, et al.
CD1c + Blood Dendritic Cells in Atopic Dermatitis are Premature and Can Produce Disease-specific Chemokines, A. Kapitány, et al.
Metabolism and internal medicine
Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance, K. Hansel, et al.
Ustekinumab as Effective Treatment for Refractory Amicrobial Pustulosis of the Folds Associated with Crohn’ s Disease, R. Al-Raddadi, et al.
Atopy, allergy and eczema
The” Alarmins” HMBG1 and IL-33 Downregulate Structural Skin Barrier Proteins and Impair Epidermal Growth, U. Nygaard, et al.
CD1c + Blood Dendritic Cells in Atopic Dermatitis are Premature and Can Produce Disease-specific Chemokines, A. Kapitány, et al.
Itch, urticaria and neurodermatology
Assessing Acute Itch Intensity: General Labelled Magnitude Scale is More Reliable than Classic Visual Analogue Scale, O. Jones, et al.
Fibroblast Growth-factor 23 and Calcium-binding Proteins are not Associated with Chronic Itch in Patients on Haemodialysis, T. Mettang, et al.
Chronic Pruritus in Primary Sjögren’ s Syndrome: Characteristics and Effect on Quality of Life, R. Valdes- Rodriguez, et al.
Psoriasis and autoimmune diseases
305 – 312 325 – 331
346 – 350 389 – 390
305 – 312 325 – 331
375 – 376 381 – 382 385 – 386
Overweight and Weight Gain Predict Psoriasis Development in a Population-based Cohort, K. Danielsen, et al. |
332 – 339 |
Patient-reported Outcomes and Clinical Response in Patients with Moderate-to-severe Plaque Psoriasis Treated |
340 – 345 |
with Tonsillectomy: A Randomized Controlled Trial, R. H. Thorleifsdottir, et al. |
Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance, |
346 – 350 |
K. Hansel, et al. |
Ustekinumab as Effective Treatment for Refractory Amicrobial Pustulosis of the Folds Associated with Crohn’ s |
389 – 390 |
Disease, R. Al-Raddadi, et al. |
Linear IgA Bullous Dermatosis in a Pregnant Woman with Autoantibodies to the Non-collagenous 16A Domain |
404 – 405 |
of Type XVII Collagen, K. Matsuura, et al. |
Eosinophilic Granulomatosis with Polyangiitis( Churg-Strauss) Relapsing as Bullous Eruption, S. Sherman, et al. |
406 – 407 |
Impetigo Herpetiformis Complicated with Intrauterine Growth Restriction Treated Successfully with Granulocyte |
410 – 411 |
and Monocyte Apheresis, N. Saito-Sasaki, et al. |
Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group, B. Horváth, et al. |
412 – 413 |
Immunology, lymphoma and HIV / AIDS
Annular Eruptive Pseudoangiomatosis and Adenovirus Infection: A Novel Clinical Variant of Paraviral Exan- 354 – 357
thems and a Novel Virus Association, A. Chuh, et al. Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than 358 – 364
Polychemotherapy, D. Michonneau, et al. Fibrinogen-like Protein 2 Activity as a Potential Biomarker for Diagnosis of Early Mycosis Fungoides, 370 – 372
S. Sherman, et al. Topical Carmustine as Monotherapy or as Multimodality Therapy for Folliculotropic Mycosis Fungoides, 373 – 374
K. M. MacArthur, et al. CD8 + T-cell-mediated Interface Dermatitis after CCR4 + T-cell Depletion by Mogamulizumab Treatment of 377 – 378
Adult T-cell Leukaemia / lymphoma, A. Ito, et al. Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with 379 – 380
Subsequent Development of Aggressive NK / T-cell Lymphoma, A. Toksoy, et al. Unusual Facial“ Acne”: A Quiz, A. Du-Thanh, et al. 414 – 415
Drug development and adverse reactions
CD8 + T-cell-mediated Interface Dermatitis after CCR4 + T-cell Depletion by Mogamulizumab Treatment of Adult T-cell Leukaemia / lymphoma, A. Ito, et al.
377 – 378
Acta Derm Venereol 2017; 97: 303 – 304